ALBO

Albireo Pharma News

Kaufen
Verkaufen
Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Albireo Pharma Inc ALBO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,0% 21,13 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
21,13
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.6.202214:00GLOBEAlbireo to Present at the William Blair Biotech Focus..
28.6.202222:02EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202222:01EDGARStatement of Changes in Beneficial Ownership (4)
24.6.202214:30GLOBEAlbireo Presents New Bylvay® (odevixibat) Data at Annual..
23.6.202214:30GLOBEAlbireo Announces Presentation of New Data in Pediatric and..
17.6.202222:08EDGARCurrent Report Filing (8-k)
08.6.202214:30GLOBEAlbireo to Present New Data at the EASL International Liver..
07.6.202214:30GLOBEAlbireo to Present New Data at the 54th Annual Meeting of..
02.6.202222:30GLOBEAlbireo to Participate at Upcoming Investor Conferences
23.5.202214:30GLOBEAlbireo Presented Data in Cholestatic Liver Diseases at..
19.5.202222:30GLOBEAlbireo to Participate in the H.C. Wainwright Global..
16.5.202223:13EDGARCurrent Report Filing (8-k)
16.5.202223:07EDGARQuarterly Report (10-q)
16.5.202222:01GLOBEAlbireo Reports Q1 2022 Financial Results and Business..
09.5.202214:30GLOBEAlbireo to Report Q1 2022 Financial Results on May 16
25.4.202222:43EDGARStatement of Changes in Beneficial Ownership (4)
25.4.202222:42EDGARStatement of Changes in Beneficial Ownership (4)
25.4.202222:42EDGARStatement of Changes in Beneficial Ownership (4)
25.4.202222:41EDGARStatement of Changes in Beneficial Ownership (4)
21.4.202214:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
21.4.202214:01EDGARProxy Statement (definitive) (def 14a)
13.4.202216:55TRMNWedbush Believes Albireo Pharma (ALBO) Still Has Room to..
29.3.202222:01EDGARStatement of Changes in Beneficial Ownership (4)
29.3.202217:15TRMNAlbireo Pharma (ALBO) Gets a Buy Rating from H.C. Wainwright
29.3.202214:30GLOBEAlbireo Completes Enrollment in Pivotal Phase 3 ASSERT Study..
28.3.202212:45TRMNAlbireo Pharma (ALBO) Received its Third Buy in a Row
07.3.202214:56EDGARStatement of Ownership (sc 13g)
02.3.202217:05TRMNAlbireo Pharma (ALBO) Received its Third Buy in a Row
02.3.202212:28TRMNWedbush Reiterates Their Buy Rating on Albireo Pharma (ALBO)
01.3.202222:26EDGARSecurities Registration: Employee Benefit Plan (s-8)
01.3.202218:15EDGARAnnual Report (10-k)
01.3.202214:43EDGARCurrent Report Filing (8-k)
01.3.202214:41SEEKAlbireo Pharma GAAP EPS of -$0.57, revenue of $32.52M
01.3.202214:30GLOBEAlbireo Reports Q4 and Year-End 2021 Financial Results and..
28.2.202219:41SEEKAlbireo Pharma Q4 2021 Earnings Preview
22.2.202214:30GLOBEAlbireo to Report Q4 and Year-End 2021 Financial Results on..
22.2.202213:00GLOBENICE Recommends Albireo’s Bylvay® (odevixibat) for All PFIC..
14.2.202222:25EDGARAmended Statement of Ownership (sc 13g/a)
14.2.202214:30GLOBEAlbireo Announces Publication of the PICTURE Study..
09.2.202222:50EDGARStatement of Ownership (sc 13g)
03.2.202212:05EDGARAmended Statement of Ownership (sc 13g/a)
25.1.202222:38EDGARStatement of Changes in Beneficial Ownership (4)
25.1.202222:38EDGARStatement of Changes in Beneficial Ownership (4)
25.1.202222:37EDGARStatement of Changes in Beneficial Ownership (4)
20.1.202222:55EDGARStatement of Changes in Beneficial Ownership (4)
20.1.202222:54EDGARStatement of Changes in Beneficial Ownership (4)
20.1.202222:53EDGARStatement of Changes in Beneficial Ownership (4)
20.1.202222:53EDGARStatement of Changes in Beneficial Ownership (4)
20.1.202222:50EDGARStatement of Changes in Beneficial Ownership (4)
20.1.202222:49EDGARStatement of Changes in Beneficial Ownership (4)
Kürzlich von Ihnen besucht
NASDAQ
ALBO
Albireo Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20220705 10:15:41